サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1439953

婦人科機器 - 世界市場の考察、競合情勢、市場予測（2030年）

Gynecological Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
婦人科機器 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の婦人科機器の市場規模は、2024年～2030年の予測期間にCAGRで8.37％の成長が見込まれます。婦人科機器の需要は主に、子宮頸部形成不全、骨盤底脱、付属器腫瘍、子宮内膜症、卵巣嚢腫、子宮筋腫などの婦人科疾患の増加によって後押しされています。さらに、革新的な先進技術の採用の増加、低侵襲治療に対する需要の増加、避妊機器や手術に対する需要の増加、家族計画や避妊に対する意識の高まり、製品の発売や承認の増加などが、2024年～2030年の予測期間における市場の全体的な成長に寄与しています。

婦人科機器の市場力学

子宮頸部異形成、骨盤底脱、付属器腫瘍、子宮内膜症、卵巣嚢腫、子宮筋腫などのさまざまな婦人科疾患の有病率が増加しています。世界保健機関（WHO）（2020）によると、2020年に世界で31万4,000件近くの卵巣がんの新規症例が報告されました。したがって、予防、早期診断、効果的なスクリーニング、治療プログラムを含む包括的なアプローチによって、がんの高い罹患率を抑制することができます。その結果、内視鏡機器や画像診断機器などの婦人科機器の需要が世界的に高まっています。

さらに、女性不妊手術、切除術、内視鏡検査、腹腔鏡検査などの外科手術の増加や、使い捨て製品の使用の増加が、製品需要を促進すると予測されます。また、最先端の革新的な技術の採用が増加していることも、産業の成長を促進すると予測されています。例えば、カリフォルニアに本社を置くEndoluxeは、2022年3月に婦人科、泌尿器科、耳鼻咽喉科、整形外科、一般外科手術向けのTowerTechを搭載したHDワイヤレス内視鏡カメラ、Endoluxe eVSを発売しました。市場は、機器の安全性を向上させ確保するための厳しい規制を受けています。

安全でない中絶やいくつかの婦人科疾患における意図しない妊娠が急増しています。このため、世界的に婦人科手術件数が増加しています。国連（2022）によると、毎年、世界の妊娠の約60％が意図しない妊娠であり、意図しない妊娠の約45％が安全でない中絶につながります。

最後に、婦人科の健康に関する意識の高まりは、市場成長の主な促進要因です。例えば、2022年9月、Rivkin Center for Ovarian CancerとAmerican Association for Cancer Researchは「Virtual Ovarian Cancer Research Series」を発表しました。このセミナーシリーズの目的は、世界中の多くの領域や機関から臨床医や研究者を集め、アイデアを共有し、卵巣がん研究の分野を発展させることでした。

したがって、上記の要因が2024年～2030年の予測期間における婦人科機器市場の成長に寄与します。

しかし、厳しい規制ガイドラインや各種機器に関連する合併症などが、婦人科機器市場の成長を抑制する可能性があります。

婦人科機器市場のセグメント分析

婦人科機器市場の製品セグメントでは、バルーンアブレーション機器カテゴリが2023年に大きな収益シェアを獲得すると予測されます。これは、子宮内膜がんの有病率の増加や、使いやすさと利便性からバルーンアブレーション機器の採用が増加していることによるものと考えられます。

WHO（2020）は、子宮内膜（子宮または子宮体部とも呼ばれる）がんは女性で6番目に多いがんであり、全体では15番目に多いがんであると述べています。同資料は、子宮頸がんは2020年に世界で60万4,000人の新規症例を占めると付け加えました。また同資料は、2040年までに世界中で79万8,000件近くの子宮体がんの新規症例が報告されると述べています。

また、子宮内膜バルーンアブレーションは、その他の手術法と比較して、回復時間の短縮、不快感の軽減、侵襲の最小化、手術時間の短縮などの利点があります。

当レポートでは、世界の婦人科機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 婦人科機器市場レポートのイントロダクション

第2章 婦人科機器市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 婦人科機器市場の主な要因の分析

  • 婦人科機器市場の促進要因
  • 婦人科機器市場の抑制要因と課題
  • 婦人科機器市場の機会

第5章 婦人科機器市場のポーターのファイブフォース分析

第6章 婦人科機器市場に対するCOVID-19の影響分析

第7章 婦人科機器市場のレイアウト

  • 製品別
    • 婦人科内視鏡機器
    • 子宮内膜アブレーション機器
    • 避妊具
    • 画像診断システム
    • 流体管理システム
    • その他
  • エンドユーザー別
    • 病院・診療所
    • 外来手術センター
    • 診断センター
  • 地域
    • 北米の婦人科機器の市場規模（2021年～2030年）
    • 欧州の婦人科機器の市場規模（2021年～2030年）
    • アジア太平洋の婦人科機器の市場規模（2021年～2030年）
    • その他の地域の婦人科機器の市場規模（2021年～2030年）

第8章 婦人科機器市場の企業と製品のプロファイル

  • Boston Scientific Corporation
  • Hologic, Inc
  • Medtronic
  • Olympus America
  • Stryker
  • UroViu Corporation
  • Medical Device Business Services, Inc.
  • Karl Storz SE & Co. KG
  • Richard Wolf GmbH.
  • COOPER SURGICAL, INC.
  • MEDGYN PRODUCTS, INC.
  • Minerva Surgical, Inc.
  • Veldana Medical SA
  • Veru Inc.
  • Teva Pharmaceutical Industries Ltd
  • Cupid Limited
  • Merck & Co Inc
  • Meril Life Sciences Pvt. Ltd
  • Pregna International Limited
  • Odyssea Pharma SPR

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Gynecological Devices Market in Global (2021-2030)
  • Table 4: Gynecological Devices Market in Global by Product (2021-2030)
  • Table 5: Gynecological Devices Market in Global by End-User (2021-2030)
  • Table 6: Gynecological Devices Market in Global by Geography (2021-2030)
  • Table 7: Gynecological Devices Market in North America (2021-2030)
  • Table 8: Gynecological Devices Market in North America by Country (2021-2030)
  • Table 9: Gynecological Devices Market in the US (2021-2030)
  • Table 10: Gynecological Devices Market in Canada (2021-2030)
  • Table 11: Gynecological Devices Market in Mexico (2021-2030)
  • Table 12: Gynecological Devices Market in Europe (2021-2030)
  • Table 13: Gynecological Devices Market in Europe by Country (2021-2030)
  • Table 14: Gynecological Devices Market in France (2021-2030)
  • Table 15: Gynecological Devices Market in Germany (2021-2030)
  • Table 16: Gynecological Devices Market in the United Kingdom (2021-2030)
  • Table 17: Gynecological Devices Market in Italy (2021-2030)
  • Table 18: Gynecological Devices Market in Spain (2021-2030)
  • Table 19: Gynecological Devices Market in the Rest of Europe (2021-2030)
  • Table 20: Gynecological Devices Market in Asia-Pacific (2021-2030)
  • Table 21: Gynecological Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Gynecological Devices Market in China (2021-2030)
  • Table 23: Gynecological Devices Market in Japan (2021-2030)
  • Table 24: Gynecological Devices Market in India (2021-2030)
  • Table 25: Gynecological Devices Market in Australia (2021-2030)
  • Table 26: Gynecological Devices Market in South Korea (2021-2030)
  • Table 27: Gynecological Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Gynecological Devices Market in the Rest of the World (2021-2030)
  • Table 29: Gynecological Devices Market in RoW by Region (2021-2030)
  • Table 30: Gynecological Devices Market in the Middle East (2021-2030)
  • Table 31: Gynecological Devices Market in Africa (2021-2030)
  • Table 32: Gynecological Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Gynecological Devices Market in Global (2021-2030)
  • Figure 4: Gynecological Devices Market in Global by Product (2021-2030)
  • Figure 5: Gynecological Devices Market in Global by End-User (2021-2030)
  • Figure 6: Gynecological Devices Market in Global by Geography (2021-2030)
  • Figure 7: Gynecological Devices Market in North America (2021-2030)
  • Figure 8: Gynecological Devices Market in North America by Country (2021-2030)
  • Figure 9: Gynecological Devices Market in the US (2021-2030)
  • Figure 10: Gynecological Devices Market in Canada (2021-2030)
  • Figure 11: Gynecological Devices Market in Mexico (2021-2030)
  • Figure 12: Gynecological Devices Market in Europe (2021-2030)
  • Figure 13: Gynecological Devices Market in Europe by Country (2021-2030)
  • Figure 14: Gynecological Devices Market in France (2021-2030)
  • Figure 15: Gynecological Devices Market in Germany (2021-2030)
  • Figure 16: Gynecological Devices Market in the United Kingdom (2021-2030)
  • Figure 17: Gynecological Devices Market in Italy (2021-2030)
  • Figure 18: Gynecological Devices Market in Spain (2021-2030)
  • Figure 19: Gynecological Devices Market in the Rest of Europe (2021-2030)
  • Figure 20: Gynecological Devices Market in Asia-Pacific (2021-2030)
  • Figure 21: Gynecological Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Gynecological Devices Market in China (2021-2030)
  • Figure 23: Gynecological Devices Market in Japan (2021-2030)
  • Figure 24: Gynecological Devices Market in India (2021-2030)
  • Figure 25: Gynecological Devices Market in Australia (2021-2030)
  • Figure 26: Gynecological Devices Market in South Korea (2021-2030)
  • Figure 27: Gynecological Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Gynecological Devices Market in the Rest of the World (2021-2030)
  • Figure 29: Gynecological Devices Market in RoW by Region (2021-2030)
  • Figure 30: Gynecological Devices Market in the Middle East (2021-2030)
  • Figure 31: Gynecological Devices Market in Africa (2021-2030)
  • Figure 32: Gynecological Devices Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0634

Gynecological Devices Market By Product (Gynecological Endoscopy Devices [Hysteroscope, Resectoscope, And Others), Endometrial Ablation Devices [Balloon Ablation Devices, Radiofrequency Ablation Devices, And Others], Contraceptive Devices [Temporary Birth Control And Permanent Birth Control], Diagnostic Imaging Systems, Fluid Management Systems, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of various gynecological ailments and increasing figure of surgical procedures across the globe

The global gynecological devices market is estimated to grow at a CAGR of 8.37% during the forecast period from 2024 to 2030. The demand for gynecological devices is primarily being boosted by the increasing figures of gynecological disorders such as cervical dysplasia, pelvic floor prolapse, adnexal tumors, endometriosis, ovarian cysts, uterine fibroids, and others. Further, the rising adoption of advanced and innovative technologies, increasing demand for minimally invasive therapy, rising demand for birth control devices and surgeries, rising awareness about family planning and birth control, and increasing product launches and approval among others are thereby contributing to the overall growth of the gynecological devices market during the forecast period from 2024-2030.

Gynecological Devices Market Dynamics:

The increase in the prevalence of various gynecological disorders such as cervical dysplasia, pelvic floor prolapse, adnexal tumors, endometriosis, ovarian cysts, uterine fibroids, and others. According to World Health Organization (WHO) 2020, 2020 nearly 314 thousand new cases of ovarian cancer were reported globally. Thus, the high incidence rate of cancer could be controlled through a comprehensive approach that includes prevention, early diagnosis, effective screening, and treatment programs. This, in turn, leads to high demand for gynecological devices such as endoscopic devices, and diagnostic imaging devices, among others globally.

Furthermore, the growing number of surgical procedures, such as female sterilization, ablation, endoscopy, and laparoscopy, as well as the increased use of disposable products, are expected to drive product demand. The increasing adoption of cutting-edge and innovative technologies is also expected to drive industry growth. Endoluxe, a California-based company, for example, launched Endoluxe eVS, an HD wireless endoscopic camera equipped with TowerTech for gynecological, urological, ENT, orthopedics, and general surgery in March 2022. The market is heavily regulated to improve and ensure the safety of the devices.

An upsurge in the figure of unintended pregnancies in unsafe abortions or some gynecological conditions. This has led to an increase in gynecological surgical volumes globally. According to the United Nations 2022, each year, around 60% of pregnancies globally are unintended and around 45% of unintended pregnancies lead to unsafe abortion.

Lastly, the increasing awareness regarding gynecological health is a major fuelling factor for the market growth. For instance, in September 2022, the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research presented the 'Virtual Ovarian Cancer Research Series'. The goal of the seminar series was to bring together clinicians and researchers from across many disciplines and institutions worldwide to share ideas and advance the field of ovarian cancer research.

Therefore, the above-mentioned factors are contributing to the growth of the gynecological devices market during the forecast period from 2024-2030.

However, stringent regulatory guidelines, complications related to various devices, and others may restrict the gynecological devices market growth.

Gynecological Devices Market Segment Analysis:

Gynecological Devices by Product (Gynecological Endoscopy Devices [Hysteroscope, Resectoscope, and Others), Endometrial Ablation Devices [Balloon Ablation Devices, Radiofrequency Ablation Devices, and Others], Contraceptive Devices [Temporary Birth Control and Permanent Birth Control], Diagnostic Imaging Systems, Fluid Management Systems, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the gynecological devices market, the balloon ablation devices category is expected to amass significant revenue share in the year 2023. This can be ascribed to the increasing prevalence of endometrial cancer and the rising adoption of these devices due to their ease of use and convenience.

The WHO in 2020 stated that endometrial (also known as womb or corpus uteri) cancer is the 6th most common cancer in women and the 15th most common cancer overall. The source added that cervix uteri cancer accounted for 604 thousand new cases in 2020, globally. The source also stated that in 2040 nearly 798 thousand new cases of corpus uteri will be reported, across the world.

Also, the advantages of endometrial balloon ablation over other surgical techniques include quicker recovery times, less discomfort, minimal invasion, and shorter operating times.

The increasing technological advancements in balloon ablation devices will also impact the demand of the segment. For instance, modified thermal balloon ablation devices with a catheter are likely to be the best treatment option in the management of heavy menstrual bleeding.

Therefore, the advantages offered by balloon ablation devices are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall gynecological devices market during the forecast period.

North America is expected to dominate the overall Gynecological Devices Market:

Among all the regions, North America is estimated to account for the largest share of the gynecological devices market in the year 2023. Owing to the significance of key growth factors rising prevalence of ovarian and cervical cancers, the growing prevalence of sexually transmitted diseases, rising use of contraceptive devices, is driving the North America gynecological devices market and are expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness also helped the market growth in this region.

The American Cancer Society estimated that nearly 19,710 new diagnoses of ovarian cancer will be reported in the United States in 2023. The same source also reported that about 13,960 new cases of invasive cervical cancer will be diagnosed in the United States in 2023. The increasing incidence of cervical and ovarian cancer will increase the number of diagnoses and treatment procedures that will be done by various gynecological devices such as endoscopy, ablation, and others. Thus, the increasing prevalence of cancers will increase the demand for gynecological devices, thereby propelling the overall market of gynecological devices.

The increasing prevalence of sexually transmitted diseases and the surging awareness regarding their demand and devices will increase the demand for many gynecological devices such as intrauterine devices (IUD), intravaginal rings, subdermal contraceptive implants, and others. The Centers for Disease Control and Prevention (CDC) 2022, reported that in 2022, approximately 2.5 million cases were reported of chlamydia, gonorrhea, and syphilis 2022.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in October 2022, Hologic, Inc., a global leader in women's health, signed a definitive agreement to acquire Bolder Surgical, a privately held, United States-based company that provides advanced energy vessel sealing surgical devices, for approximately USD 160 million, subject to working capital and other customary closing adjustments. The complementary acquisition of Bolder Surgical is likely to add to Hologic's surgical product line, which includes the NovaSure, an endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure, tissue removal devices for the treatment of intrauterine fibroids and polyps, the Acessa laparoscopic radiofrequency ablation system for the treatment of fibroids, and the Fluent, fluid management system for streamlining hysteroscopic procedures. Thus, such strategic steps help to increase the demand for gynecological devices, thereby driving the North America gynecological devices market forward during the forecast period.

Gynecological Devices Market Key Players:

Some of the key market players operating in the gynecological devices market include Boston Scientific Corporation, Hologic, Inc., Medtronic, Olympus America, Stryker, UroViu Corporation, Medical Device Business Services, Inc., Karl Storz SE & Co. KG, Richard Wolf GmbH., COOPER SURGICAL, INC., MEDGYN PRODUCTS, INC., Minerva Surgical, Inc., Veldana Medical SA, Veru Inc., Teva Pharmaceutical Industries Ltd, Cupid Limited, Merck & Co Inc., Meril Life Sciences Pvt. Ltd, Pregna International Limited, Odyssea Pharma SPR, and others.

Recent Developmental Activities in the Gynecological Devices Market:

In June 2022, UroViu Corp launched the new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intrauterine examinations.

In February 2022, Mithra and Searchlight Pharma announced the commercial launch of Mithra's vaginal contraceptive ring Myring under the brand name Haloette in Canada.

In October 2022, Hologic, Inc., a global leader in women's health, launched its expanded Omni® suite, a comprehensive gynecological surgical offering designed to optimize diagnostic and operative hysteroscopy, in Europe, Africa, and the Middle East (EMEA). The offering now includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal, and the Omni 5 French seal, which complement the company's existing portfolio of GYN surgical solutions and extend physicians' choices.

In November 2022, Hologic, Inc., a global leader in women's health, launched the NovaSure V5 global endometrial ablation (GEA) device.

Key Takeaways from the Gynecological Devices Market Report Study

Market size analysis for current gynecological devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the gynecological devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years

Key companies dominating the global gynecological devices market.

Various opportunities available for the other competitor in the gynecological devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current gynecological devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for gynecological devices market growth in the coming future?

Target Audience who can be benefited from this Gynecological Devices Market Report Study

Gynecological devices products providers

Research organizations and consulting companies

Gynecological devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in gynecological devices

Various End-users who want to know more about the gynecological devices market and the latest technological developments in the gynecological devices market.

Frequently Asked Questions for the Gynecological Devices Market:

1. What are gynecological devices?

Gynecological devices refer to surgical and monitoring devices used for gynecological conditions and disorders, such as fluid management, endometrial ablation, gynecological endoscopy, and contraceptive devices.

2. What is the market for global gynecological devices?

The global gynecological devices market is estimated to grow at a CAGR of 8.37% during the forecast period from 2024 to 2030.

3. What are the drivers for the global gynecological devices market?

The demand for gynecological devices is primarily being heightened by the increasing prevalence of gynecological disorders such as cervical dysplasia, pelvic floor prolapse, adnexal tumors, endometriosis, ovarian cysts, uterine fibroids, and others. In addition, the advancement in gynecological devices that aid in improving the efficiency of the minimally invasive technique for surgeries and the development of advanced imaging devices, such as 3D endoscopes, increasing device launches and approvals, among others thereby contribute to the overall growth of the gynecological devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global gynecological devices market?

Some of the key market players operating in the gynecological devices market include Boston Scientific Corporation, Hologic, Inc., Medtronic, Olympus America, Stryker, UroViu Corporation, Medical Device Business Services, Inc., Karl Storz SE & Co. KG, Richard Wolf GmbH., COOPER SURGICAL, INC., MEDGYN PRODUCTS, INC., Minerva Surgical, Inc., Veldana Medical SA, Veru Inc., Teva Pharmaceutical Industries Ltd, Cupid Limited, Merck & Co Inc., Meril Life Sciences Pvt. Ltd, Pregna International Limited, Odyssea Pharma SPR, and others.

5. Which region has the highest share in the gynecological devices market?

North America is expected to dominate the overall gynecological devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of gynecological disorders such as ovarian and cervical cancers, the growing prevalence of sexually transmitted diseases, the rising use of contraceptives, a type of gynecological device amongst females, the North American gynecological devices market is expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about gynecological diseases also helped the market growth in this region.

Table of Contents

1.Gynecological Devices Market Report Introduction

2. Gynecological Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Gynecological Devices Market Key Factors Analysis

  • 4.1. Gynecological Devices Market Drivers
    • 4.1.1. Rising prevalence of gynecological disorders
    • 4.1.2. Increasing volume of surgical procedures such as female sterilization, ablation, endoscopy, and laparoscopy
    • 4.1.3. Technological advancements in diagnostic imaging and medical software
  • 4.2. Gynecological Devices Market Restraints and Challenges
    • 4.2.1. Stringent Regulatory Guidelines
    • 4.2.2. Complications related to various devices
  • 4.3. Gynecological Devices Market Opportunities
    • 4.3.1. Increasing use of robotics in gynecological devices

5. Gynecological Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Gynecological Devices Market

7. Gynecological Devices Market Layout

  • 7.1. By Product
    • 7.1.1. Gynecological Endoscopy Devices
      • 7.1.1.1. Hysteroscope
      • 7.1.1.2. Resectoscope
      • 7.1.1.3. Others
    • 7.1.2. Endometrial Ablation Devices
      • 7.1.2.1. Balloon Ablation Devices
      • 7.1.2.2. Radiofrequency Ablation Devices
      • 7.1.2.3. Others
    • 7.1.3. Contraceptive Devices
      • 7.1.3.1. Temporary Birth Control
      • 7.1.3.2. Permanent Birth Control
    • 7.1.4. Diagnostic Imaging Systems
    • 7.1.5. Fluid Management Systems
    • 7.1.6. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Diagnostic Centers
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.1.1. United States Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Gynecological Devices Market Size in USD million (2021-2030)
    • 7.3.2. Europe Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.2.1. France Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Gynecological Devices Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.3.1. China Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.3.3. India Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Gynecological Devices Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW) Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.4.1. Middle East Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Gynecological Devices Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Gynecological Devices Market Size in USD million (2021-2030)

8. Gynecological Devices Market Company and Product Profiles

  • 8.1. Boston Scientific Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Hologic, Inc
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Medtronic
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Olympus America
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Stryker
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. UroViu Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Medical Device Business Services, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Karl Storz SE & Co. KG
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Richard Wolf GmbH.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. COOPER SURGICAL, INC.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. MEDGYN PRODUCTS, INC.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Minerva Surgical, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Veldana Medical SA
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Veru Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Teva Pharmaceutical Industries Ltd
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Cupid Limited
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Merck & Co Inc
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Meril Life Sciences Pvt. Ltd
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Pregna International Limited
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Odyssea Pharma SPR
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us